Amanote Research
Register
Sign In
New Drug Option for Men With Aggressive Prostate Cancer
Cancer
- United States
doi 10.1002/cncr.31753
Full Text
Open PDF
Abstract
Available in
full text
Categories
Cancer Research
Oncology
Date
October 1, 2018
Authors
Carrie Printz
Publisher
Wiley
Related search
Nine-Year Prostate Cancer Survival Differences Between Aggressive Versus Conservative Therapy in Men With Advanced and Metastatic Prostate Cancer
Cancer
Cancer Research
Oncology
Mutational Profile of Aggressive, Localised Prostate Cancer From African Caribbean Men Versus European Ancestry Men
European Urology
Urology
The PROMIS of a New Diagnostic Pathway for Men With Suspected Prostate Cancer
Clinical Oncology
Nuclear Medicine
Radiology
Imaging
Oncology
Ailanthone: A New Potential Drug for Castration-Resistant Prostate Cancer
Chinese Journal of Cancer
Hypofractionation and Prostate Cancer: A Good Option for Africa?
South African Journal of Oncology
Prostate Cancer Organoids: A Potential New Tool for Testing Drug Sensitivity
Expert Review of Anticancer Therapy
Oncology
Pharmacology
Metformin and Prostate Cancer: A New Role for an Old Drug
Current Urology Reports
Medicine
Urology
Do New Zealand Men With Prostate Cancer Benefit From a Mediterranean-Style Diet?
Aggressive Variants of Castration-Resistant Prostate Cancer
Clinical Cancer Research
Cancer Research
Oncology